Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

Total article views   HTML views PDF downloads Totals
22,924 Dovepress* 20,573+ 2,630 23,203
PubMed Central* 2,351 985 3,336
Totals 22,924 3,615 26,539
*Since 6 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
23 1 0 0 7 15

View citations on PubMed Central and Google Scholar